 Natus Medical Incorporated NTUS the Company or Natus, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced its first quarter revenue estimate and withdrew its full year 2020 guidance. For the first quarter 2020, the Company expects to report revenue between 109 million and 110 million compared to its previous guidance of 113 million and 117 million. The Company will report its first quarter financial results after the close of the market on Thursday, April 30th. 